|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1997-10-30
|
|
pubmed:abstractText |
In this study the efficacy and safety of calcium heparin administered alone for the prevention of fetal loss related to antiphospholipid antibodies (aPL) were evaluated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-856X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
499-505
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9307857-Abortion, Spontaneous,
pubmed-meshheading:9307857-Adult,
pubmed-meshheading:9307857-Antibodies, Antiphospholipid,
pubmed-meshheading:9307857-Autoimmune Diseases,
pubmed-meshheading:9307857-Female,
pubmed-meshheading:9307857-Fibrinolytic Agents,
pubmed-meshheading:9307857-Heparin,
pubmed-meshheading:9307857-Humans,
pubmed-meshheading:9307857-Immunoglobulin G,
pubmed-meshheading:9307857-Immunoglobulin M,
pubmed-meshheading:9307857-Infant, Newborn,
pubmed-meshheading:9307857-Male,
pubmed-meshheading:9307857-Placenta,
pubmed-meshheading:9307857-Pregnancy,
pubmed-meshheading:9307857-Pregnancy Complications, Hematologic,
pubmed-meshheading:9307857-Pregnancy Outcome,
pubmed-meshheading:9307857-Prospective Studies,
pubmed-meshheading:9307857-Twins
|
|
pubmed:articleTitle |
A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss.
|
|
pubmed:affiliation |
Chair and Division of Rheumatology, University of Padova, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
